NASDAQ: CYTKCytokinetics Inc Stock Ownership - Who owns Cytokinetics?
Insider buying vs selling
Have Cytokinetics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Edward M. Md Kaye | Director | 2026-01-15 | 197 | $63.44 | $12.50kBuy |
| Wendell Wierenga | Director | 2026-01-15 | 98 | $63.44 | $6.22kBuy |
| Nancy Wysenski | Director | 2026-01-15 | 98 | $63.44 | $6.22kBuy |
| Robert Arthur Harrington | Director | 2026-01-15 | 197 | $63.44 | $12.50kBuy |
| James M. Daly | Director | 2026-01-15 | 197 | $63.44 | $12.50kBuy |
| John T. Henderson | Director | 2026-01-15 | 334 | $63.44 | $21.19kBuy |
| Andrew Callos | EVP Chief Commercial Officer | 2026-01-05 | 15,000 | $23.26 | $348.90kBuy |
| Andrew Callos | EVP Chief Commercial Officer | 2026-01-05 | 15,000 | $60.28 | $904.20kSell |
| Andrew Callos | EVP Chief Commercial Officer | 2026-01-02 | 885 | $63.16 | $55.90kSell |
| Andrew Callos | EVP Chief Commercial Officer | 2026-01-02 | 885 | $37.63 | $33.30kBuy |
CYTK insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CYTK insiders and whales buy or sell their stock.
CYTK Shareholders
What type of owners hold Cytokinetics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| T Rowe Price Investment Management Inc | 15.61% | 19,080,496 | $1.22B | Institution |
| Blackrock Inc | 12.70% | 15,525,747 | $993.80M | Institution |
| Fmr LLC | 10.71% | 13,091,647 | $838.00M | Institution |
| Vanguard Group Inc | 9.70% | 11,856,795 | $758.95M | Institution |
| Michael Schmertzler | 7.96% | 9,730,131 | $622.83M | Insider |
| Wellington Management Group LLP | 6.06% | 7,408,561 | $474.22M | Institution |
| Tudor Investment Corp Et Al | 4.91% | 6,000,000 | $384.06M | Institution |
| State Street Corp | 4.59% | 5,617,334 | $359.57M | Institution |
| Deep Track Capital LP | 3.52% | 4,300,000 | $275.24M | Institution |
| Bank Of America Corp | 2.50% | 3,061,796 | $195.99M | Institution |
CYTK vs Biotech Stocks
Cytokinetics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.